Underserved US healthcare IT market offers growth prospects:
This article was originally published in Clinica
The US healthcare IT market is characterised as still having low adoption rates across many segments, with many physicians remaining unwilling to use healthcare IT solutions due to the lack of technical expertise or staff, perceived changes to workflow and the absence of a need to adopt. "The benefits of adopting IT are often realised at the employer and insurance plan level as opposed to the provider level," says Konstantinos Nikolopoulos, author of the new Frost & Sullivan study, An overview of the US healthcare market and implications for the healthcare IT industry. To leverage the market's potential, vendors need to educate third-party payers on the benefits of funding IT solutions for providers. Furthermore, vendors should seek to collaborate with insurance companies and employers to increase adoption of healthcare IT. For details, see: www.frost.com.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.